Skip to main content

Burnham Institute to Use Cyntellect's Imaging System in Collaboration

NEW YORK (GenomeWeb News) – High-speed biomedical imaging company Cyntellect said today that it is collaborating with the Burnham Institute for Medical Research to develop new applications for the company’s in situ cellular imaging tool.
 
The San Diego-based company said the agreement gives the Burnham researchers access to its LEAP cell imaging and laser processing platform, while Cyntellect gains commercial rights to certain discoveries produced by the collaboration.
 
The LEAP live cell analysis and processing system incorporates high-speed optical imaging with image analysis and laser cell manipulation, which can be used in cell cloning, image-based cell purification of adherent and non-adherent cell types, and laser-based macromolecule delivery into cells, including siRNA, small molecules, proteins, and quantum dots.
 
Cyntellect said it expects that the new applications it develops through the collaboration can be used to understand stem cell differentiation factors and pathways and to generate cell populations that could be used as stem cell therapeutics.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.